Skip to main content
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. logo

CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. — Investor Relations & Filings

Ticker · 000661 ISIN · CNE0000007J8 LEI · 300300X04OTKZG18WD66 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,288 across all filing types
Latest filing 2019-12-12 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000661

About CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD.

https://ccht.jl.cn

CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. is a diversified enterprise primarily focused on the research, development, production, and distribution of biopharmaceuticals and healthcare products. The company operates through several key subsidiaries, most notably GeneScience Pharmaceuticals, which specializes in recombinant human growth hormones and pediatric endocrinology treatments. Its product portfolio includes biological drugs, vaccines, and traditional Chinese medicines, targeting therapeutic areas such as growth disorders, infectious diseases, and oncology. The group emphasizes technological innovation and maintains a significant presence in the domestic market while expanding its international footprint. In addition to its core life sciences business, the company maintains interests in real estate development and infrastructure management.

Recent filings

Filing Released Lang Actions
第九届董事会第十八次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 18th meeting of the 9th Board of Directors of Changchun High-tech Industry (Group) Co., Ltd. It includes information about board meeting procedures, voting results, amendments to the company charter, cash management proposals, project investment delays, and plans to convene a shareholders' meeting. The content focuses on board decisions and governance matters rather than financial results or audit opinions. It is not a full annual or interim report, nor an earnings release or audit report. The document is not a simple announcement of a report publication but a substantive disclosure of board resolutions. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is 3549 characters, which is sufficient for a detailed board meeting resolution announcement. Confidence is high due to the clear focus on board meeting resolutions and governance.
2019-12-12 Chinese
关于使用部分暂时闲置自有资金进行非保本低风险型现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Changchun High-tech Industry (Group) Co., Ltd. regarding the use of temporarily idle self-owned funds for non-principal-protected low-risk cash management. It details the board meeting resolution, investment scope, risk control measures, and authorization for management to implement the cash management within a specified limit and period. The document is a formal announcement of a corporate financing activity related to cash management and investment of idle funds, not a financial report or earnings release. It does not contain financial statements or detailed financial results but rather a description of a capital management decision and authorization. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is 2413 characters, which is consistent with an announcement rather than a full report.
2019-12-12 Chinese
中德证券有限责任公司关于公司部分募集资金投资项目投产延期的核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed verification opinion from a sponsoring institution (中德证券有限责任公司) regarding the delay in the production start of certain fundraising investment projects by 长春高新技术产业（集团）股份有限公司. It references regulatory approvals, fundraising amounts, project investment details, and compliance with Shenzhen Stock Exchange rules. The document is not a full annual or interim financial report, nor is it a simple announcement. It is a formal verification and compliance opinion related to the use of raised funds and project delays, which aligns with the category of Capital/Financing Update (CAP) as it deals with fundraising project progress and compliance. The document length is 3133 characters, which is substantive and contains detailed information rather than a brief announcement or certification. Therefore, the best fit is CAP.
2019-12-12 Chinese
独立董事关于第九届董事会第十八次会议审议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on specific board meeting matters, including the use of idle funds for low-risk cash management and the delay of a fundraising investment project. It references compliance with stock exchange rules and regulatory guidelines but does not contain financial statements or detailed financial results. The document is a formal opinion related to board decisions rather than a full report or announcement of voting results. It fits best under Board/Management Information (MANG) as it concerns board-level decisions and opinions on company matters.
2019-12-12 Chinese
第九届监事会第十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Changchun High-tech Industry (Group) Co., Ltd. regarding the postponement of production for a fundraising investment project. It details the meeting date, voting results, and reasons for the delay in project production timelines. The document does not contain financial statements or detailed financial data but is an official announcement of a board meeting decision. It is not an annual report, audit report, or earnings release. It is not a regulatory filing or certification letter. The content fits best under Board/Management Information (MANG) as it relates to decisions made by the supervisory board about company projects and operations.
2019-12-12 Chinese
北京市康达律师事务所关于公司发行股份及可转换债券购买资产并募集配套资金暨关联交易之实施情况的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the implementation of a major asset restructuring transaction involving the issuance of shares and convertible bonds to purchase assets and raise supporting funds. It references approvals from regulatory bodies such as the China Securities Regulatory Commission, details on the transaction structure, approvals by the board and shareholders, asset transfer and registration, and compliance with relevant laws. The document is not a financial report, earnings release, or management discussion but a legal opinion on the transaction's implementation and compliance. This type of document is best classified under Regulatory Filings (RNS) as it is a legal compliance and regulatory disclosure document related to a capital/asset transaction but not a direct capital/financing update or a merger filing. It is also not a report publication announcement since it contains substantive legal opinion content rather than just announcing a report's availability.
2019-12-09 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.